Potential Role of GcMAF in Suppressing the Severity of COVID-19-induced Immune Responses: Lesson Learned from HIV
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Analysis of the Biological Properties of Blood Plasma Protein with GcMAF Functional Activity.
Dolgova E, Kirikovich S, Levites E, Ruzanova V, Proskurina A, Ritter G Int J Mol Sci. 2022; 23(15).
PMID: 35897653 PMC: 9330714. DOI: 10.3390/ijms23158075.
References
1.
Saburi E, Saburi A, Ghanei M
. Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside. Caspian J Intern Med. 2017; 8(4):228-238.
PMC: 5686300.
DOI: 10.22088/cjim.8.4.228.
View
2.
Tang N, Li D, Wang X, Sun Z
. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4):844-847.
PMC: 7166509.
DOI: 10.1111/jth.14768.
View
3.
Yamamoto N
. Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the envelope glycoprotein gp160 of human immunodeficiency virus Type 1. AIDS Res Hum Retroviruses. 2006; 22(3):262-71.
DOI: 10.1089/aid.2006.22.262.
View
4.
Inui T, Kuchiike D, Kubo K, Mette M, Uto Y, Hori H
. Clinical experience of integrative cancer immunotherapy with GcMAF. Anticancer Res. 2013; 33(7):2917-9.
View
5.
Lee W, Galbraith R
. The extracellular actin-scavenger system and actin toxicity. N Engl J Med. 1992; 326(20):1335-41.
DOI: 10.1056/NEJM199205143262006.
View